Posaconazole (Noxafil) for invasive fungal infections.
D000935:Antifungal Agents / Q000627:therapeutic use*; D002180:Candidiasis, Oral / Q000517:prevention & control; D004347:Drug Interactions; D006801:Humans; D009181:Mycoses / Q000517:prevention & control*; D014230:Triazoles / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use*
D000935:Antifungal Agents; D014230:Triazoles; C101425:posaconazole